{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:12:58Z","timestamp":1768252378463,"version":"3.49.0"},"reference-count":36,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2020,7,1]]},"DOI":"10.5551\/jat.49841","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T22:04:47Z","timestamp":1572386687000},"page":"695-710","source":"Crossref","is-referenced-by-count":21,"title":["High sdLDL Cholesterol can be Used to Reclassify Individuals with Low Cardiovascular Risk for Early Intervention: Findings from the Chinese Multi-Provincial Cohort Study"],"prefix":"10.5551","volume":"27","author":[{"given":"Yue","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuju","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University; Beijing Institute of Heart, Lung and Blood Vessel Diseases; The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education; Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Joint committee for guideline revision. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol, 2018; 15: 1-29"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Z, Riccardi G, Taskinen MR, Tokgozoglu L, Monique Verschuren WM, Vlachopoulos C, Wood DA, Luis Zamorano J and Cooney MT: 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Rev Esp Cardiol (Engl Ed), 2017; 70: 115","DOI":"10.1016\/j.rec.2017.01.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Jr., Sperling L, Virani SS and Yeboah J: 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. J Am Coll Cardiol, 2019; 73: e285-e350","DOI":"10.1016\/j.jacc.2018.11.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, Zhao Z and Zhang Y: Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol, 2018; 260: 196-203","DOI":"10.1016\/j.ijcard.2017.12.069"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fernandez-Friera L, Fuster V, Lopez-Melgar B, Oliva B, Garcia-Ruiz JM, Mendiguren J, Bueno H, Pocock S, Ibanez B, Fernandez-Ortiz A and Sanz J: Normal ldl-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. J Am Coll Cardiol, 2017; 70: 2979-2991","DOI":"10.1016\/j.jacc.2017.10.024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M and R. N: High-dose versus low-dose pitavastatin in japanese patients with stable coronary artery disease (real-cad): a randomized superiority trial. Circulation, 2018; 137: 1997-2009","DOI":"10.1161\/CIRCULATIONAHA.117.032615"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Patel KV, Pandey A and de Lemos JA: Conceptual framework for addressing residual atherosclerotic cardiovascular disease risk in the era of precision medicine. Circulation, 2018; 137: 2551-2553","DOI":"10.1161\/CIRCULATIONAHA.118.035289"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Krauss RM: Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol, 2010; 21: 305-311","DOI":"10.1097\/MOL.0b013e32833b7756"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Diffenderfer MR and Schaefer EJ: The composition and metabolism of large and small ldl. Curr Opin Lipidol, 2014; 25: 221-226","DOI":"10.1097\/MOL.0000000000000067"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Thongtang N, Diffenderfer MR, Ooi EMM, Barrett PHR, Turner SM, Le NA, Brown WV and Schaefer EJ: Metabolism and proteomics of large and small dense ldl in combined hyperlipidemia: effects of rosuvastatin. J Lipid Res, 2017; 58: 1315-1324","DOI":"10.1194\/jlr.M073882"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tsai MY, Steffen BT, Guan W, McClelland RL, Warnick R, McConnell J, Hoefner DM and Remaley AT: New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol, 2014; 34: 196-201","DOI":"10.1161\/ATVBAHA.113.302401"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E and Ballantyne CM: Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (aric) study. Arterioscler Thromb Vasc Biol, 2014; 34: 1069-1077","DOI":"10.1161\/ATVBAHA.114.303284"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko HR, Rowland CM, Glynn RJ, Ridker PM and Krauss RM: Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (jupiter) trial. Circulation, 2015; 132: 2220-2229","DOI":"10.1161\/CIRCULATIONAHA.115.016857"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Shiffman D, Louie JZ, Caulfield MP, Nilsson PM, Devlin JJ and Melander O: LDL subfractions are associated with incident cardiovascular disease in the malmo prevention project study. Atherosclerosis, 2017; 263: 287-292","DOI":"10.1016\/j.atherosclerosis.2017.07.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Chen PC, Jeng JS, Hsu HC, Su TC, Chien KL and Lee YT: Carotid atherosclerosis progression and risk of cardiovascular events in a community in taiwan. Sci Rep, 2016; 6: 25733","DOI":"10.1038\/srep25733"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Katakami N, Mita T, Gosho M, Takahara M, Irie Y, Yasuda T, Matsuoka TA, Osonoi T, Watada H and Shimomura I: Clinical utility of carotid ultrasonography in the prediction of cardiovascular events in patients with diabetes: a combined analysis of data obtained in five longitudinal studies. J Atheroscler Thromb, 2018; 25: 1053-1066","DOI":"10.5551\/jat.43141"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ulf N\u00e4slund, Nawi Ng, Anna Lundgren, Eva Fh\u00e4rm, Christer Gr\u00f6nlund, Helene Johansson, Bernt Lindahl, Prof Bertil Lindahl, Kristina Lindvall, Stefan K Nilsson, Maria Nordin, Steven Nordin, Emma Nyman, Joacim Rockl\u00f6v, Davide Vanoli, Lars Weinehall, Patrik Wennberg, Per Wester, Margareta Norberg and VIPVIZA trial group: Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (vipviza): a pragmatic, open-label, randomised controlled trial. LANCET, 2018; 393: 133-142","DOI":"10.1016\/S0140-6736(18)32818-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Liu J, Hong Y, D&apos;Agostino RB, Sr., Wu Z, Wang W, Sun J, Wilson PW, Kannel WB and Zhao D: Predictive value for the chinese population of the framingham chd risk assessment tool compared with the chinese multi-provincial cohort study. JAMA, 2004; 291: 2591-2599","DOI":"10.1001\/jama.291.21.2591"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Qi Y, Fan J, Liu J, Wang W, Wang M, Sun J, Xie W, Zhao F, Li Y and Zhao D: Cholesterol-overloaded hdl particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study. J Am Coll Cardiol, 2015; 65: 355-363","DOI":"10.1016\/j.jacc.2014.11.019"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Qi Y, Liu J, Wang W, Wang M, Zhao F, Sun J and Zhao D: Apolipoprotein E-containing high-density lipoprotein (hdl) modifies the impact of cholesterol-overloaded hdl on incident coronary heart disease risk: a community-based cohort study. J Clin Lipidol, 2018; 12: 89-98.e2","DOI":"10.1016\/j.jacl.2017.11.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ito Y, Fujimura M, Ohta M and Hirano T: Development of a homogeneous assay for measurement of small dense ldl cholesterol. Clin Chem, 2011; 57: 57-65","DOI":"10.1373\/clinchem.2010.149559"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Shuaib M A, Laura F D, David L, Carolyn E B, Nina B R, Benjamin L W, Anand R, Darren K M, James A dL, Scott M G, Jarett D B and Khera A: Long-term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease. Circulation, 2018; 138: 2315-2325","DOI":"10.1161\/CIRCULATIONAHA.118.034273"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Maeda S, Nakanishi S, Yoneda M, Awaya T, Yamane K, Hirano T and Kohno N: Associations between small dense ldl, hdl subfractions (hdl2, hdl3) and risk of atherosclerosis in japanese-americans. J Atheroscler Thromb, 2012; 19: 444-452","DOI":"10.5551\/jat.11445"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Aoki T, Yagi H, Sumino H, Tsunekawa K, Araki O, Kimura T, Nara M, Ogiwara T, Nakajima K and Murakami M: Relationship between carotid artery intimamedia thickness and small dense low-density lipoprotein cholesterol concentrations measured by homogenous assay in japanese subjects. Clin Chim Acta, 2015; 442: 110-114","DOI":"10.1016\/j.cca.2015.01.010"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Wilkins JT, Li RC, Sniderman A, Chan C and Lloyd-Jones DM: Discordance between apolipoprotein b and ldl-cholesterol in young adults predicts coronary artery calcification: the cardia Study. J Am Coll Cardiol, 2016; 67: 193-201","DOI":"10.1016\/j.jacc.2015.10.055"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hsu SH-J, Jang M-H, Torng P-L and Su T-C: Positive association between small dense low-density lipoprotein cholesterol concentration and biomarkers of inflammation, thrombosis, and prediabetes in non-diabetic adults. J Atheroscler Thromb, 2019; 26: 624-635","DOI":"10.5551\/jat.43968"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hsu H, Hsu P, Cheng MH, Ito Y, Kanda E, Schaefer EJ and Ai M: Lipoprotein subfractions and glucose homeostasis in prediabetes and diabetes in taiwan. J Atheroscler Thromb, 2019; 26: 890-914","DOI":"10.5551\/jat.48330"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Rizzo M and Berneis K: Low-density lipoprotein size and cardiovascular risk assessment. QJM, 2006; 99: 1-14","DOI":"10.1093\/qjmed\/hci154"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH and Schaefer EJ: Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. Am J Cardiol, 2008; 101: 315-318","DOI":"10.1016\/j.amjcard.2007.08.035"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Dashty M, Motazacker MM, Levels J, de Vries M, Mahmoudi M, Peppelenbosch MP and Rezaee F: Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism. Thromb Haemost, 2014; 111: 518-530","DOI":"10.1160\/TH13-02-0178"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Hirano T: Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb, 2018; 25: 771-782","DOI":"10.5551\/jat.RV17023"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Hirayama S and Miida T: Small dense ldl: an emerging risk factor<b> <\/b>for cardiovascular disease. Clin Chim Acta, 2012; 414: 215-224","DOI":"10.1016\/j.cca.2012.09.010"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Gao S and Liu J: Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chronic Dis Transl Med, 2017; 3: 89-94","DOI":"10.1016\/j.cdtm.2017.02.008"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Gao S, Zhao D, Qi Y, Wang W, Wang M, Sun J, Liu J, Li Y and Liu J: Circulating oxidized low-density lipoprotein levels independently predict 10-year progression of subclinical carotid atherosclerosis: a community-based cohort study. J Atheroscler Thromb, 2018; 25: 1032-1043","DOI":"10.5551\/jat.43299"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tani M, Kawakami A, Mizuno Y, Imase R, Ito Y, Kondo K, Ishii H and Yoshida M: Small dense ldl enhances thp-1 macrophage foam cell formation. J Atheroscler Thromb, 2011; 18: 698-704","DOI":"10.5551\/jat.7161"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV and Orekhov AN: Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxid Med Cell Longev, 2017; 2017: 1273042","DOI":"10.1155\/2017\/1273042"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/7\/27_49841\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T22:37:16Z","timestamp":1664750236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/7\/27_49841\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.49841","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}